About Us

For nearly three decades, we have had the privilege of working alongside sponsors, CROs, and research organizations as clinical development evolved.

Our journey mirrors many of the major scientific and technological transitions that have shaped modern drug development.

In the late 1990s, we were already working with ambulatory blood pressure monitoring (ABPM) data and device-based data extraction in cardiovascular studies—at a time when paper CRFs and manual data entry were still the norm.

As new therapeutic areas gained momentum, we supported projects ranging from pain management and patient-reported outcomes to cholesterol-lowering therapies, sexual health research, endocrinology, gastroenterology, dermatology, and infectious diseases.

We participated in studies involving some of the first long-acting insulin products, contributed to programs supporting the emergence of biologics, and later became involved in numerous vaccine development initiatives. During the COVID-19 pandemic, our teams worked intensively to support sponsors facing unprecedented timelines and operational challenges.

Today, our work increasingly focuses on advanced analytics, real-world evidence, imaging data, genomics, and data-intensive clinical research.

Technology has transformed just as dramatically as medicine. When Planimeter was founded, internet connectivity was still emerging and clinical data were collected primarily on paper. More than twenty years ago, we developed our first electronic data capture platform and have continued to expand it over time with Trial Master File and e-learning capabilities.

Over the years, we have participated in approximately 300 projects across 22 countries, supporting around 80 clients, including multinational pharmaceutical companies, biotechnology firms, academic organizations, and fellow CROs.

Throughout these changes, one thing has remained constant: our commitment to turning complex clinical data into reliable evidence and better decisions.

For nearly three decades, we have had the privilege of working alongside sponsors, CROs, and research organizations as clinical development evolved.

Our journey mirrors many of the major scientific and technological transitions that have shaped modern drug development.

In the late 1990s, we were already working with ambulatory blood pressure monitoring (ABPM) data and device-based data extraction in cardiovascular studies—at a time when paper CRFs and manual data entry were still the norm.

As new therapeutic areas gained momentum, we supported projects ranging from pain management and patient-reported outcomes to cholesterol-lowering therapies, sexual health research, endocrinology, gastroenterology, dermatology, and infectious diseases.

We participated in studies involving some of the first long-acting insulin products, contributed to programs supporting the emergence of biologics, and later became involved in numerous vaccine development initiatives. During the COVID-19 pandemic, our teams worked intensively to support sponsors facing unprecedented timelines and operational challenges.

Today, our work increasingly focuses on advanced analytics, real-world evidence, imaging data, genomics, and data-intensive clinical research.

Technology has transformed just as dramatically as medicine. When Planimeter was founded, internet connectivity was still emerging and clinical data were collected primarily on paper. More than twenty years ago, we developed our first electronic data capture platform and have continued to expand it over time with Trial Master File and e-learning capabilities.

Over the years, we have participated in approximately 300 projects across 22 countries, supporting around 80 clients, including multinational pharmaceutical companies, biotechnology firms, academic organizations, and fellow CROs.

Throughout these changes, one thing has remained constant: our commitment to turning complex clinical data into reliable evidence and better decisions.

22 Countries

120+ Sponsors

350+ Studies

Since 1997

Mission

Our mission is to help sponsors transform clinical and real-world data into trustworthy evidence through rigorous statistical thinking, efficient technology, and practical operational support. We aim to provide the scientific insight, analytical expertise, and digital tools required to accelerate development while maintaining the highest standards of quality and reliability.

Vision

We envision a future where evidence generation is faster, more transparent, and more data-driven than ever before. By combining biostatistics, programming, real-world evidence, advanced analytics, and modern digital platforms, we strive to become a trusted partner for organizations developing the next generation of therapies and medical innovations.

Values

Scientific Rigor

We believe that evidence matters only when it is generated, analyzed, and interpreted with scientific discipline. Statistical rigor is not a final quality check—it is the foundation of every decision we support.


Long-Term Perspective

Clinical development is measured in years, not weeks. We value lasting partnerships and sustainable solutions over short-term fixes, building relationships that often extend across multiple programs and therapeutic areas.


Practical Problem Solving

Complexity is unavoidable in clinical research. Our role is not to add complexity but to transform it into clear, actionable insights that support better decisions.


Continuous Learning

From paper CRFs to real-world evidence and AI-assisted analytics, our industry never stands still. We continuously adapt our methods, technologies, and skills while preserving the scientific principles that remain timeless.

Building Evidence

From cardiovascular studies and long-acting insulin programs to vaccines, real-world evidence, and advanced analytics, our focus has remained the same: transforming complex clinical data into meaningful evidence and better decisions.

See how this experience translates into real projects.

Explore Case Studies →